Wellington Management Group’s Achieve Life Sciences ACHV Stock Holding History

Wellington Management Group’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.32M	Buy	+1,426,915	New	+$6.8M	﹤0.01%	1309

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Wellington Management Group's ACHV Position: Q2 2026 in Review

Wellington Management Group opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 1,426,915 shares worth $9.32M. The stake represents ﹤0.01% of the portfolio and ranks #1309 among its holdings.

111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

Wellington Management Group held 1,426,915 shares of Achieve Life Sciences worth $9.32M as of Q2 2026.
Achieve Life Sciences was a new Wellington Management Group position in Q2 2026.
Achieve Life Sciences made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1309 holding.
111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.